HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Kobayashi Selected Research

Cytokines

3/2019Relationship between clinical course of nivolumab-related myositis and immune status in a patient with Hodgkin's lymphoma after allogeneic hematopoietic stem cell transplantation.
9/2007Effects of inhaled nanoparticles on acute lung injury induced by lipopolysaccharide in mice.
12/2006Effects of organic chemicals derived from ambient particulate matter on lung inflammation related to lipopolysaccharide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takahiro Kobayashi Research Topics

Disease

8Multiple Myeloma
03/2024 - 08/2014
7Pneumonia (Pneumonitis)
01/2022 - 11/2005
7Neoplasms (Cancer)
10/2020 - 01/2017
7Inflammation (Inflammations)
01/2016 - 06/2004
4Hemorrhage
01/2023 - 03/2017
4Heart Failure
10/2021 - 01/2016
4Infections
03/2020 - 01/2010
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2024 - 01/2022
3Carcinoma (Carcinomatosis)
02/2022 - 01/2013
3Myocardial Infarction
10/2021 - 01/2016
3Renal Insufficiency (Renal Failure)
12/2019 - 04/2010
3Asthma (Bronchial Asthma)
12/2004 - 06/2002
2Ulcerative Colitis
04/2024 - 12/2023
2Fever (Fevers)
12/2023 - 01/2022
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2023 - 04/2021
2COVID-19
12/2023 - 01/2022
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 01/2022
2Atrial Fibrillation
01/2023 - 10/2021
2Acute Coronary Syndrome
01/2023 - 03/2017
2Neoplasm Metastasis (Metastasis)
02/2022 - 01/2017
2Disease Progression
01/2022 - 03/2019
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2008
2Chronic Renal Insufficiency
01/2022 - 10/2021
2Lymphoma (Lymphomas)
01/2022 - 01/2021
2Acute Kidney Injury (Acute Renal Failure)
10/2021 - 04/2010
2Residual Neoplasm
04/2021 - 01/2017
2Type 2 Diabetes Mellitus (MODY)
06/2019 - 09/2012
2Kidney Calculi (Kidney Stone)
01/2016 - 02/2014
2Cardiovascular Diseases (Cardiovascular Disease)
01/2008 - 03/2006
2Acute Lung Injury
09/2007 - 06/2004
2Chronic Bronchitis
12/2004 - 06/2002
2Lung Diseases (Lung Disease)
12/2004 - 06/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2024
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2024
1Crohn Disease (Crohn's Disease)
01/2024
1Arthralgia (Joint Pain)
12/2023
1Adult-Onset Still's Disease
12/2023
1Edema (Dropsy)
12/2023
1Philadelphia Chromosome
12/2023
1Frailty
09/2023
1VEXAS syndrome
08/2023
1Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta)
01/2023
1Anemia
01/2023
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2023
1Hypothyroidism
12/2022
1Aspiration Pneumonia
12/2022

Drug/Important Bio-Agent (IBA)

7Lenalidomide (CC 5013)FDA Link
09/2023 - 08/2014
71-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
02/2008 - 06/2002
6Dexamethasone (Maxidex)FDA LinkGeneric
09/2023 - 02/2008
5AntigensIBA
06/2016 - 04/2004
5Vehicle Emissions (Emissions, Vehicle)IBA
02/2008 - 06/2002
4Messenger RNA (mRNA)IBA
02/2024 - 11/2005
4Particulate MatterIBA
09/2008 - 03/2006
3venetoclaxIBA
02/2024 - 01/2022
3omega-Chloroacetophenone (Mace)IBA
01/2023 - 03/2017
3Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2016
3CytokinesIBA
03/2019 - 12/2006
3AutoantibodiesIBA
05/2014 - 01/2010
3SootIBA
09/2008 - 11/2005
2BNT162 VaccineIBA
12/2023 - 01/2022
2mRNA VaccinesIBA
12/2023 - 01/2022
2Ointments (Pastes)IBA
12/2022 - 02/2021
2Clarithromycin (Biaxin)FDA LinkGeneric
01/2022 - 06/2018
2Immunoglobulin G (IgG)IBA
12/2019 - 06/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2019 - 06/2006
2NivolumabIBA
03/2019 - 09/2018
2InterferonsIBA
03/2019 - 05/2012
2Rituximab (Mabthera)FDA Link
11/2018 - 01/2018
2Pioglitazone (Actos)FDA Link
01/2016 - 09/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2016 - 09/2012
2melamineIBA
02/2014 - 04/2010
2cyanuric acidIBA
02/2014 - 04/2010
2ChemokinesIBA
08/2012 - 11/2005
2EndotoxinsIBA
09/2007 - 12/2006
2LipopolysaccharidesIBA
09/2007 - 12/2006
2OzoneIBA
06/2004 - 04/2004
1Circulating Tumor DNAIBA
03/2024
1Azathioprine (Imuran)FDA LinkGeneric
01/2024
1Infliximab (Remicade)FDA Link
01/2024
1ponatinibIBA
12/2023
1Sulfasalazine (Azulfidine)FDA LinkGeneric
12/2023
1Tyrosine Kinase InhibitorsIBA
12/2023
1ixazomibIBA
09/2023
1ParaproteinsIBA
09/2023
1EnzymesIBA
08/2023
1Brentuximab VedotinIBA
01/2023
1Clopidogrel (Plavix)FDA Link
01/2023
1AnticoagulantsIBA
01/2023
1Parathyroid Hormone (Parathormone)IBA
01/2023
1Prasugrel HydrochlorideFDA Link
01/2023

Therapy/Procedure

13Therapeutics
04/2024 - 01/2009
5Percutaneous Coronary Intervention
01/2023 - 01/2016
4Drug Therapy (Chemotherapy)
12/2023 - 01/2017
3Stents
01/2023 - 02/2022
2Aftercare (After-Treatment)
04/2024 - 01/2017
2Transplantation
01/2024 - 01/2019
2Renal Dialysis (Hemodialysis)
01/2022 - 12/2016
2Glycemic Control
06/2019 - 09/2012
2Nephroureterectomy
12/2018 - 10/2017
2Cystectomy
12/2018 - 11/2018